IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q3 2022 Holdings

Filed 2022-11-15 | 14 holdings | $49.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$49.3M184,64899.5%
United Therapeutics Corp(UTHR)COM91307C102$42.0K200,4070.1%
Regeneron Pharmaceuticals(REGN)COM75886F107$41.9K60,8890.1%
Alkermes PLC(ALKS)COMG01767105$31.5K1,411,6820.1%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$30.6K589,3600.1%
Embecta Corp(EMBC)COM29082K105$29.5K1,024,2000.1%
Exelixis Inc(EXEL)COM30161Q104$28.6K1,821,4750.1%
Cardinal Health Inc(CAH)COM14149Y108$22.5K336,7420.0%
Taro Pharmaceutical IndusCOMM8737E108$17.4K580,7930.0%
Mckesson Corp(MCK)COM58155Q103$10.8K31,9130.0%
Kodiak Sciences Inc(KOD)COM50015M109$3.6K469,3880.0%
Eagle Pharmaceuticals Inc(EGRX)COM269796108$3.2K121,0830.0%
Vanda Pharmaceuticals Inc(VNDA)COM921659108$3.1K312,2990.0%
Nextcure IncCOM65343E108$8631,2980.0%